CEVEC Grants Full Distribution Rights for CAP®-CDM Cell Culture Medium and CAP®-CDM Feed to Xell
CAP®-CDM Medium and Feed was developed by Xell for high performance cell cultures of the CAP®Go cell lines commercialized by CEVEC
While in the past CAP®-CDM was sold exclusively by CEVEC to its customers, Xell will be the future sole distributor of the product
Cologne, Germany, January 25, 2019
CEVEC Pharmaceuticals GmbH (CEVEC), the expert in the production of tailor-made recombinant glycoproteins and gene therapy vectors today announced that it has granted full distribution rights for CAP®-CDM Medium and CAP®-CDM Feed to Xell AG.
CAP®-CDM Medium and Feed were developed by Xell on behalf of CEVEC for culturing CEVEC’s proprietary CAP®Go cell lines. Going forward Xell will be the sole distributor of the product and exclusively sell CAP®-CDM Medium and Feed to customers from academia as well as the biotechnology and pharmaceutical industry.